Mishan at Keybanc urged a “BUY” on Hill-Rom in a recent interview with The Wall Street Transcript published on Friday …
“Hill-Rom also has a “buy” rating. This is a company that has been transitioning itself over multiple years, through acquisition, away from its core U.S. hospital bed position. When you think Hill-Rom, most people think hospital beds, and that used to be a significant percentage of its revenue. The company would get beaten around by hospital capital spending trends, and the volatility in the business made it difficult to invest in it over time.”
Positive Fundamental Outlook on Medical Devices and Equipment Companies - The Wall Street Transcript
TWST: Can you tell the readers anything about how your coverage might have changed since the last time we spoke? Mr. Mishan: I now cover what are called the CDMOs, as in contract development and manufacturing organizations. My coverage now includes t
Yahoo Reader: Any idea why HRC has not been taken over by a larger player in the health field? With the limited number of shares outstanding and the huge amounts held by institutions, a takeover could be done rather easily in my view.
X axis : Stocks Price Correlation Coefficient Y axis : Quantity of stocks May-2016 1,000 Day Parameter 4,338 NYSE Stocks Price Analysis This stock mode of correlation coefficient is 0.9 In other words, the correlation coefficient of the other stocks
HRC appears to suggest upside opportunity given the EPS growth % next Y at 11.83%. if you guys have questions you should ask awesom-eSTOCKS. They often respond to my emails which is helpful.
Largest Gainers on the NASDAQ & NYSE ---> T0pMarketGalners.c0m